Key research themes
1. How do bacterial microcompartments and extracellular electron transfer systems facilitate anaerobic ethanolamine utilization in pathogens?
This research theme focuses on the molecular and physiological mechanisms by which bacteria, particularly human pathogens like Listeria monocytogenes, utilize ethanolamine (EA) under anaerobic conditions. The investigation centers on the role of bacterial microcompartments (BMCs) that encapsulate ethanolamine catabolic enzymes and the involvement of extracellular electron transfer (EET) systems, particularly flavin-based EET, in maintaining redox balance and supporting growth. These mechanisms are critical for pathogen survival and virulence in nutrient-limited and anaerobic environments such as the human gastrointestinal tract, making them of interest for understanding bacterial metabolism and potential therapeutic targeting.
2. What is the role of acetaldehyde metabolism and aldehyde dehydrogenase (ALDH2) activation in modulating ethanol intake and its neurobehavioral effects?
This theme investigates the metabolic and neuropharmacological contributions of acetaldehyde, the primary ethanol metabolite, in modulating ethanol's reinforcing properties, intake behavior, and toxicity. It particularly emphasizes the role of aldehyde dehydrogenase-2 (ALDH2) in acetaldehyde catabolism within the central nervous system, exploring pharmacological activation of ALDH2 as a strategy to attenuate ethanol intake. Understanding these metabolic pathways is essential for developing treatments for alcohol use disorders by targeting acetaldehyde bioavailability and its neurobehavioral effects.
3. How can modulation of glutamatergic and monoaminergic transporter systems influence ethanol self-administration and potential treatment strategies for alcohol use disorder?
This line of research examines the neurochemical mechanisms underlying ethanol intake, focusing on the role of transporter proteins such as organic cation transporter 3 (OCT3) and the cystine-glutamate antiporter (system x_c−). It evaluates how ethanol affects monoamine uptake via these transporters, influences glutamate homeostasis, and how pharmacological modulation (e.g., N-acetylcysteine) affects ethanol-related behaviors. These insights inform development of novel pharmacotherapeutics targeting transporter systems to reduce ethanol self-administration and relapse in alcohol use disorder.